(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202206 | 202106 | % Var | 202206 | 202106 | % Var | 202203 | 202103 | % Var | |
| Sales | 49328.80 | 36652.90 | 34.58 | 49328.80 | 36652.90 | 34.58 | 155859.80 | 141160.50 | 10.41 |
| Other Income | 1762.10 | 2116.90 | -16.76 | 1762.10 | 2116.90 | -16.76 | 11968.80 | 1920.70 | 523.15 |
| PBIDT | 14986.50 | 4550.30 | 229.35 | 14986.50 | 4550.30 | 229.35 | 38654.40 | 24490.80 | 57.83 |
| Interest | 870.70 | 1074.60 | -18.97 | 870.70 | 1074.60 | -18.97 | 3881.00 | 2675.20 | 45.07 |
| PBDT | 14115.80 | 1820.00 | 675.59 | 14115.80 | 1820.00 | 675.59 | 16568.10 | 20920.00 | -20.80 |
| Depreciation | 3745.00 | 3069.30 | 22.01 | 3745.00 | 3069.30 | 22.01 | 13499.50 | 12364.30 | 9.18 |
| PBT | 10370.80 | -1249.30 | -930.13 | 10370.80 | -1249.30 | -930.13 | 3068.60 | 8555.70 | -64.13 |
| TAX | 252.80 | 133.50 | 89.36 | 252.80 | 133.50 | 89.36 | 4068.50 | 131.70 | 2989.22 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 10118.00 | -1382.80 | -831.70 | 10118.00 | -1382.80 | -831.70 | -999.90 | 8424.00 | -111.87 |
| Equity | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 |
| PBIDTM(%) | 30.38 | 12.41 | 144.72 | 30.38 | 12.41 | 144.72 | 24.80 | 17.35 | 42.95 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: